We have located links that may give you full text access.
Journal Article
Review
Preventing Post-Traumatic Stress Disorder following Childbirth: A Systematic Review and Meta-Analysis.
American Journal of Obstetrics and Gynecology 2023 December 19
OBJECTIVE: Women can develop post-traumatic stress disorder (PTSD) in response to experienced or perceived traumatic, often medically complicated, childbirth; U.S. prevalence of these events remains high. Currently, no recommended treatment exists in routine care for preventing or mitigating maternal childbirth-related PTSD (CB-PTSD). We provide a systematic review and meta-analysis of clinical trials testing any therapy to prevent or treat CB-PTSD.
DATA SOURCES: PsycInfo, PsycArticles, PubMed (MEDLINE), ClinicalTrials.gov, CINAHL, ProQuest, Sociological Abstracts, Google Scholar, Embase, Web of Science, ScienceDirect, Scopus, and CENTRAL were searched for eligible trials published through September 2023.
STUDY ELIGIBILITY CRITERIA: Trials were included if they were interventional, evaluated any therapy for CB-PTSD, for indication of symptoms or before PTSD onset, and written in English.
STUDY APPRAISAL AND SYNTHESIS METHODS: Independent coders extracted sample characteristics and intervention information of eligible studies and evaluated trials using Downs and Black's quality checklist and Cochrane's method for risk of bias.
RESULTS: 41 studies (32 randomized controlled trials, 9 non-randomized trials) were reviewed. They tested brief psychological therapies entailing debriefing, trauma-focused (including Cognitive Behavioral Therapy and Expressive Writing), memory consolidation/reconsolidation blockage, mother-infant focused, and educational interventions. Trials targeted secondary prevention to buffer CB-PTSD usually after traumatic childbirth (n=24), tertiary preventions in women with probable CB-PTSD (n=14), and primary prevention during pregnancy (n=3). Meta-analysis of combined randomized secondary preventions showed moderate effects for reducing CB-PTSD symptoms against treatment as usual (standardized mean difference, SMD =-0.67; 95% CI -0.92,-0.42). Single-session therapy within 96 hours postpartum was helpful (SMD=-0.55). Brief structured trauma-focused therapies and semi-structured midwife-led dialogue-based psychological counseling showed the largest effects (SMD=-0.95 and SMD=-0.91). Other treatment approaches (e.g., Tetris game, mindfulness, mother-infant focused) warrant more research. Tertiary preventions represented smaller effects vs. secondary, but are potentially clinically meaningful (SMD = -0.37 (-0.60; -0.14)). Antepartum educational approaches may help, but insufficient empirical evidence exists.
CONCLUSIONS: Brief trauma-focused and non-trauma-focused psychological therapies delivered in in the early period following traumatic childbirth offer a critical and feasible opportunity to buffer symptoms of childbirth-related PTSD. Future research integrating diagnostics and biological measures can inform treatment utility and the mechanisms at work.
DATA SOURCES: PsycInfo, PsycArticles, PubMed (MEDLINE), ClinicalTrials.gov, CINAHL, ProQuest, Sociological Abstracts, Google Scholar, Embase, Web of Science, ScienceDirect, Scopus, and CENTRAL were searched for eligible trials published through September 2023.
STUDY ELIGIBILITY CRITERIA: Trials were included if they were interventional, evaluated any therapy for CB-PTSD, for indication of symptoms or before PTSD onset, and written in English.
STUDY APPRAISAL AND SYNTHESIS METHODS: Independent coders extracted sample characteristics and intervention information of eligible studies and evaluated trials using Downs and Black's quality checklist and Cochrane's method for risk of bias.
RESULTS: 41 studies (32 randomized controlled trials, 9 non-randomized trials) were reviewed. They tested brief psychological therapies entailing debriefing, trauma-focused (including Cognitive Behavioral Therapy and Expressive Writing), memory consolidation/reconsolidation blockage, mother-infant focused, and educational interventions. Trials targeted secondary prevention to buffer CB-PTSD usually after traumatic childbirth (n=24), tertiary preventions in women with probable CB-PTSD (n=14), and primary prevention during pregnancy (n=3). Meta-analysis of combined randomized secondary preventions showed moderate effects for reducing CB-PTSD symptoms against treatment as usual (standardized mean difference, SMD =-0.67; 95% CI -0.92,-0.42). Single-session therapy within 96 hours postpartum was helpful (SMD=-0.55). Brief structured trauma-focused therapies and semi-structured midwife-led dialogue-based psychological counseling showed the largest effects (SMD=-0.95 and SMD=-0.91). Other treatment approaches (e.g., Tetris game, mindfulness, mother-infant focused) warrant more research. Tertiary preventions represented smaller effects vs. secondary, but are potentially clinically meaningful (SMD = -0.37 (-0.60; -0.14)). Antepartum educational approaches may help, but insufficient empirical evidence exists.
CONCLUSIONS: Brief trauma-focused and non-trauma-focused psychological therapies delivered in in the early period following traumatic childbirth offer a critical and feasible opportunity to buffer symptoms of childbirth-related PTSD. Future research integrating diagnostics and biological measures can inform treatment utility and the mechanisms at work.
Full text links
Related Resources
Trending Papers
Renin-Angiotensin-Aldosterone System: From History to Practice of a Secular Topic.International Journal of Molecular Sciences 2024 April 5
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities.Diabetologia 2024 April 17
British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease.Rheumatology 2024 April 17
Albumin: a comprehensive review and practical guideline for clinical use.European Journal of Clinical Pharmacology 2024 April 13
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app